Synchro REPLA:Y Laser Systems Cleared for Higher Fluence and Larger Spot Size

DEKA Medical, developer and distributor of light-based aesthetics systems, has received additional Food and Drug Administration (FDA) clearance for its Synchro REPLA:Y family of three laser platforms, allowing for a maximum power of 180W and a 24mm spot size, the largest currently available.

Each Synchro REPLA:Y platform—the Excellium 3.4, the Excellium HP and the Premium 1.4.2—is designed to treat a range of indications, including hair removal, pseudo folliculitis barbae, benign pigmented lesions, wrinkles and photocoagulation of vascular lesions. Their new 180W setting now allows for maximum fluence combined with the largest 24mm spot size, enabling physicians to offer efficient high-speed treatments with each multi-wavelength work station.

For more information, visit

More in Treatments